
Pharmacy Research Institute sp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Pharmacy Research Institute operates in research, development and pharmaceuticals. The company’s headquarters are in Poznań at 332 Bukowska Street.
Financials
Revenue history (in k)
Financial insight
- The statement flags a going concern risk. Brak
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 89 days for 2021).
- 202502/07/2026
- 202415/07/2025
- 202313/07/2024
- 202231/07/2023
- 202112/10/2022
- 202014/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Cosmeceutical bases
- Private-label cosmetics
- Cosmetic raw materials
- Research technology licensing
- Biotechnology testing
- Laboratory testing
- Technology consulting
Websites
- pharmacyinstitute.plPharmacy Research Institute – badania, rozwój, farmacjaWordPress 7.1ElementorApache
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 4,750 | $128,309.02 | 95% | |
Others | 250 | $6,753.11 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $1,234,886.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 15, 2021 | Aid for research and development projects: industrial research | $988.6K$988,621 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 15, 2021 | Aid for research and development projects: experimental development | $177K$177,032 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jun 15, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $67,951$67,951 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-05-01 | Research and development on a new range of cosmeceutical preparations using active substances of natural origin with enhanced penetration into the skin and regenerative and protective properties. | $1.2M$1,226,706 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cleansery sp. z o.o. | $963,751.05 | cleansery.com | ||
| ACC Chemicals sp. z o.o. | $822,109.23 | accchemicals.pl | ||
| MGP Cosmetics sp. z o.o. | $430,951.83 | mgp-cosmetics.eu | ||
| Sara Cosmetics sp. z o.o. | $366,345.14 | saracosmetics.com.pl | ||
| NTS Laboratory sp. z o.o. | $297,226.62 | ntslab.pl | ||
| Poplawska Group sp. z o.o. | $255,857.19 | poplawskagroup.pl | ||
| Colabio sp. z o.o. | $161,519.02 | colabio.pl | ||
| Aube Lab Polska S.K.A. | $161,001.64 | swit.com.pl | ||
| Infusi sp. z o.o. | $66,719.11 | infusi.pl | ||
| Silesia Brand Collective sp. z o.o. | $37,752.07 | sbcollective.pl |
Change history
FAQ
Last updated: 2026-07-04
